Therapeutic monoclonal antibodies in oncology: an update: Monoclonal antibodies directed at growth factor receptors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (4)
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
2000 • 748 citations
The addition of Herceptin (humanized anti-HER2 antibody) to first-line chemotherapy for HER2-overexpressing metastatic breast cancer (HER2+ MBC) markedly increases anti-cancer activity: A randomized, multinational controlled phase II trial.
1998 • 366 citations
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
1996 • 103 citations
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
1994 • 68 citations
Cited By (0)
No citing papers found in database